Telomere length and multiple sclerosis: a Mendelian randomization study

Int J Neurosci. 2024 Jun;134(3):229-233. doi: 10.1080/00207454.2022.2098737. Epub 2022 Jul 13.

Abstract

Purpose of the study: Previous studies have established that telomere length is associated with multiple sclerosis (MS). However, confounding factors and reverse causality bias can impair observational research. Here, we conducted a two-sample MR study to see if telomere length is causally linked to MS using publically available GWAS summary statistics.

Materials and methods: We screened 13 independent single-nucleotide polymorphisms (SNPs) related to leukocyte telomere length in a recent genome-wide association meta-analysis, which was available for 78,592 samples of European ancestry. The summary statistics for MS were from the latest meta-analyses conducted by the International Multiple Sclerosis Genetics Consortium (IMSGC), which included 115,803 European participants (47,429 MS, 68,374 controls).

Results: We found that leukocyte telomere length and MS are correlated (IVW estimate of odds ratio (OR): 2.13 per 1-SD increase in genetically determined telomere length, 95% confidence interval (CI): 1.55-2.92, p = 3.18 × 10-6).

Conclusion: Our MR study supported that leukocyte telomere length and MS have a positive causal relationship. Further researches are warranted to elucidate the physiological mechanism.

Keywords: Mendelian randomization; Multiple sclerosis; telomere.

Publication types

  • Meta-Analysis

MeSH terms

  • Genome-Wide Association Study*
  • Humans
  • Mendelian Randomization Analysis
  • Multiple Sclerosis* / genetics
  • Odds Ratio
  • Telomere / genetics